Clinical trial
Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for…
NCT00325286 · Creighton University, Other · Unknown status
Key facts
| NCT number | NCT00325286 |
|---|---|
| Title | Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder |
| Official title | Open Label Prophylaxis Study of Lithium Plus Extended- Release Carbamazepine (Equetro®) Combination for Rapid Cycling Bipolar Disorder |
| Lead sponsor | Creighton University, Other |
| Collaborators | Shire Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Lithium Plus Extended- Release Carbamazepine |
| Enrollment | 20 |
| Start date | May 1, 2006 |
| Completion | Mar 1, 2008 |
| First posted | May 12, 2006 |
| Last update posted | Dec 14, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: